Lombardia Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-5,942
Closed -$327K 190
2016
Q2
$327K Sell
5,942
-99,023
-94% -$5.27M 0.02% 176
2016
Q1
$5.3M Sell
104,965
-106,024
-50% -$5.19M 0.28% 105
2015
Q4
$10.6M Sell
210,989
-410
-0.2% -$20.7K 0.53% 70
2015
Q3
$9.96M Hold
211,399
0.48% 85
2015
Q2
$11.5M Sell
211,399
-244,022
-54% -$13.7M 0.39% 98
2015
Q1
$25M Buy
455,421
+83,564
+22% +$4.73M 0.75% 45
2014
Q4
$20.2M Buy
371,857
+62,705
+20% +$3.49M 0.58% 68
2014
Q3
$17.5M Buy
309,152
+46,132
+18% +$2.59M 0.52% 82
2014
Q2
$14.5M Buy
+263,020
New +$14.3M 0.39% 98

Other funds holding MRK

Lombardia Capital Partners's MRK Position: Q3 2016 in Review

Lombardia Capital Partners sold out of Merck (MRK) in Q3 2016, closing a stake of 5,942 shares — an estimated $327K sold.

Lombardia Capital Partners first reported a position in MRK in Q2 2014 and held it in 9 quarters. The position peaked at $25M in Q1 2015. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Lombardia Capital Partners reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
  • Lombardia Capital Partners sold 5,942 Merck shares in Q3 2016, an estimated $327K.
  • Lombardia Capital Partners first reported a position in Merck in Q2 2014 and held it in 9 quarters.
  • Lombardia Capital Partners's Merck position peaked at $25M in Q1 2015.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Lombardia Capital Partners's 13F filing for Q3 2016, filed 9 Nov 2016.